Effectiveness of Pharmaceutical Care in the Adherence of Systemic Lupus Erythematosus Treatment
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Systemic Lupus Erythematosus
Related studies linked through entity extraction aliases.
Multiple Ascending Dose Study To Assess The Safety Profile Of SAR113244 Versus Placebo In Lupus Male And Female Patients
- Status
- COMPLETED
- Phase
- PHASE1
Individualized Patient Decision Making for Treatment Choices Among Minorities With Lupus
- Status
- COMPLETED
- Phase
- NA
Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients
- Status
- COMPLETED
- Phase
- PHASE1
Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the Blood
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus
- Status
- COMPLETED
- Phase
- PHASE1
Activity and Nutrition Trial in Lupus to Energize and Renew
- Status
- COMPLETED
- Phase
- NA
Evaluation of Belimumab Impact on a BLyS Activity Signature Test in the Absence of Confounding Polypharmacy
- Status
- UNKNOWN
- Phase
- PHASE4
Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches
- Status
- COMPLETED
- Phase
- PHASE2
Molecular Mechanisms Characteristics in Systemic Lupus Erythematous Autoimmune Disease
- Status
- WITHDRAWN
- Phase
- N/A
Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus
- Status
- COMPLETED
- Phase
- PHASE1
A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus.
- Status
- COMPLETED
- Phase
- PHASE2
Dose-escalation Trial of Anti-C5aR Antibody in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
- Status
- COMPLETED
- Phase
- PHASE2
Belimumab Treatment Holiday and Treatment Re-start Study in Lupus Patients
- Status
- COMPLETED
- Phase
- PHASE3
Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Single Doses and Multiple Doses of BIIB059 (Litifilimab) in Healthy Volunteers and Participants With Systemic Lupus Erythematosus
- Status
- COMPLETED
- Phase
- PHASE1
Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)
- Status
- TERMINATED
- Phase
- PHASE2
Low-dose IL-2( Interleukin-2) Treatment in SLE
- Status
- COMPLETED
- Phase
- NA
CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis
- Status
- WITHDRAWN
- Phase
- PHASE3
Nelfinavir in Systemic Lupus Erythematosus
- Status
- TERMINATED
- Phase
- PHASE2